
Pathology and subtype
Pathology report, primary site, subtype, margins, lymph node status, and stage if known.
For melanoma pathology, staging, recurrence, immunotherapy, targeted therapy, or clinical route questions, start with one short form. We help organize reports for hospital-doctor consultation and estimated route planning.
After submission, we check whether the record set is ready for a hospital oncology discussion.

Pathology report, primary site, subtype, margins, lymph node status, and stage if known.

BRAF/NRAS/KIT or related testing, PET/CT or MRI, recurrence status, and disease distribution.

Prior PD-1, combination therapy, targeted therapy, side effects, and follow-up needs.
We help organize the report set and route questions before hospital consultation and travel planning.
MedChinaNow coordinates records, communication, pricing questions, and travel planning. Treatment suitability, access, pricing, timing, and outcomes must be assessed by the hospital doctor.
Leave diagnosis type, country, email, and contact method.
We ask for pathology, imaging, mutation testing, and prior treatment details.
We organize the case around immunotherapy, targeted therapy, or recurrence questions.
Hospital consultation, estimated cost questions, schedule, and translation.
Keep communication organized after the first review or China visit.
No. We coordinate the route. Treatment suitability and outcomes must be assessed by qualified doctors.
It may be important for melanoma route discussions. Submit first and we will ask what reports are available.
We can prepare the record set and questions for hospital consultation. Availability and suitability are hospital decisions.
Advanced oncology travel starts with record clarity, hospital fit, estimated cost questions, and schedule planning.
One short form lets us start organizing the case for hospital specialist discussion.